Frequently Asked Questions

1. Why is the Company delayed in making its periodic report filings with the SEC?

As disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 (the "2017 Form 10-K"), the filing of that report was delayed significantly as a result of the delay in the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, as well as the substantial time and effort devoted to ongoing remediation of the material weaknesses in internal control over financial reporting disclosed in those reports.  (Response dated 5/14/18)

2. Is the Company current with its financial filings now that the 2017 10-K is filed?

No. While the Company is now current with all outstanding annual filings, Hanger has not yet completed the preparation of its financial statements for the quarter end March 31, 2018.  However, it has previously provided certain preliminary estimates of cash flows and liquidity in a Current Report on Form 8-K filed with the SEC on May 10,2018.  (Response dated 5/14/18)

3. When will you file your 10-Q for the first quarter of 2018?

The Company has commenced the preparation of its financial statements for the quarter end March 31, 2018 and intends to file those as expeditiously as possible.  (Response dated 5/14/18)

4. What are the next steps after filing the 10-Q?

Subsequent to reporting and filing Hanger's second quarter 2018 results, the Company currently plans to commence the process of relisting on a national securities exchange, which it anticipates will occur in the autumn timeframe.  (Response dated 5/14/18)

5. How do I buy or sell common shares of Hanger?

You may buy or sell Hanger common stock in the same way you buy and sell other securities through the institutional, online or retail broker-dealer of your choice.  (Response dated 2/26/16)

6. Does the Company plan to get re-listed on the NYSE or another major national stock exchange?

Yes, the Company intends to become current with its SEC filings as expeditiously as is possible, after which time the Company intends to apply for listing on a national stock exchange, which it anticipates will occur in the autumn timeframe.  (Response dated 5/14/18)

7. Who is Hanger, Inc.'s transfer agent?

P.O. Box 30170
College Station, TX 77842-3170

8. How can I contact Hanger, Inc. Investors Relations?


Phone: 512.777.3690

Postal Mail:
Investor Relations
Hanger, Inc., Inc.
10910 Domain Drive, Suite 300
Austin, TX 78758

9. Who is the Company's independent registered public accounting firm?

PricewaterhouseCoopers LLP
300 West 6th Street, Suite 1800
Austin, TX 78701

10. How can I obtain Hanger's public SEC filings?

All Hanger, Inc. public filings with the SEC are available at no charge on the SEC's public website at You can also find these filings in the SEC filings section​ of Hanger's website.

Disclosures About Forward-Looking Statements

This page contains certain “forward-looking statements” relating to the Company. All statements, other than statements of historical fact included herein, are “forward looking statements,” including statements regarding the timing of filing of, and the outcome of the Company’s work in connection with, completing certain financial statements and other financial data. These forward-looking statements are often identified by the use of forward-looking terminology such as “preliminary,” “intends,” “expects,” “plans” or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. These uncertainties include, but are not limited to, the risk that additional information may arise during the course of the Company’s ongoing financial statement preparation and closing processes that would require the Company to make additional adjustments or revisions to its estimates or financial statements and other financial data, to identify additional material weaknesses, or to take any other necessary action relating to the Company’s accounting practices; the time required to complete the Company’s financial statements and other financial data and accounting review; the time required to prepare its periodic reports for filings with the Securities and Exchange Commission; the impact of the Tax Cuts and Jobs Act on the Company’s financial statements; any regulatory review of, or litigation relating to, the Company’s accounting practices, financial statements and other financial data, periodic reports or other corporate actions; changes in the demand for our O&P products and services; uncertainties relating to the results of operations or recently acquired O&P patient care clinics; the Company’s ability to enter into and derive benefits from managed-care contracts; the Company’s ability to successfully attract and retain qualified O&P clinicians; federal laws governing the health care industry; uncertainties inherent in investigations and legal proceedings; governmental policies affecting O&P operations;  and other risks and uncertainties generally affecting the health care industry. For additional information and risk factors that could affect the Company, see its Form 10 K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission. The information contained in this press release is made only as of the date hereof, even if subsequently made available by the Company on its website or otherwise.